MediXall Group, Inc. Completes First Phase Launch of Healthcare Platform and Expands Medical Advisory Board and Executive Team


Ft Lauderdale, FL, Jan. 16, 2018 (GLOBE NEWSWIRE) -- MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry is pleased to announce that the company executed a limited launch of a working version of its Healthcare Platform in December 2017 to a target market segment in South Florida, and is now preparing a broader-based market rollout for early Q1 2018 based on the data and feedback received during that launch. The market response to the platform, and other related products that were offered, was extremely positive and the company generated significant revenue during that period.

In preparation for the full launch, MediXall Group is currently interviewing several nationally recognized public relations firms and will be engaging one or more of them to manage the marketing outreach and broadcast messaging as the company grows this year.

The Company has now reached a growth point where additional leadership personnel is required for the next phases of expansion, so we are making appointments to the Advisory Board and Executive Team. We will be announcing these appointments as soon as agreements have been finalized.

Over the past 12 months, MediXall Group has built a robust MediXaid Provider Network of healthcare providers in South Florida, which includes licensed and certified diagnostic centers, internists, general practitioners, dentists, psychotherapists, chiropractors, physical therapists and acupuncturists, among others. The MediXaid Provider Network growth has accelerated over that period, surpassing 5000 healthcare providers registered in its Early Adopter Program, several hundred of whom are in process of being formally credentialed and submitted for review and approval by the Credentialing Committee. The exact number may change daily, so conservative approximate figures are presented here.

The MediXall Credentialing Committee is a panel of experienced and respected physicians from a variety of specialties. Members of the Committee are educated as to the credentialing process and have agreed to hold a Review meeting monthly to evaluate new providers for approval. The Medical Director and Committee members will be announced in a future release.

Michael Swartz, VP of Operations of MediXall Group, said, “Since inception we have been committed to delivering a solution that better connect consumers with high-quality healthcare providers and wellness services. We have spent the past year refining our consumer-centric platform, which enables our Provider Network to engage MediXall Platform users with the level of price transparency and digital convenience that consumers have come to expect in every other aspect of their lives.”

If you would like to preview the MediXall Healthcare Platform, please contact the company.

About MediXall Group, Inc.

MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol “MDXL.” The Company believes its revolutionary approach will help drive much needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. MediXall’s first acquisition was MediXaid®, a developing cloud-based software platform that promises to revolutionize the way people purchase healthcare goods and services.

About MediXall Healthcare Platform

The first product MediXall is developing is the MediXall Healthcare Platform, which is on schedule for a first quarter 2018 launch. The MediXall Platform is a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. With MediXall.com, patient/clients find price transparency and the ability to make informed choices based on price, location and schedule for requested medical products and services. In this era of rapidly increasing deductibles and healthcare costs, the cloud-based MediXall platform is designed to be transformational and disruptive to traditional methods of medical care and provisioning of medical services to the consumer.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


            

Contact Data